Net Cash Provided by (Used in) Operating Activities |
2.14M |
USD |
-6.8% |
Q2 2025 |
Q1 2026 |
Net Cash Provided by (Used in) Financing Activities |
-14K |
USD |
|
Q2 2025 |
Q1 2026 |
Net Cash Provided by (Used in) Investing Activities |
-336K |
USD |
-740% |
Q2 2025 |
Q1 2026 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2025 |
Q1 2026 |
Common Stock, Shares, Issued |
8.5M |
shares |
0% |
Q2 2025 |
Q1 2026 |
Common Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q2 2025 |
Q1 2026 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.79M |
USD |
-20.7% |
Q2 2025 |
Q1 2026 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
-100% |
Q2 2025 |
Q1 2026 |
Deferred Tax Assets, Valuation Allowance |
3K |
USD |
-70% |
Q1 2025 |
FY 2025 |
Payments to Acquire Property, Plant, and Equipment |
133K |
USD |
+26.7% |
Q2 2025 |
Q1 2026 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
8.1M |
USD |
-0.11% |
Q2 2025 |
Q1 2026 |
Property, Plant and Equipment, Gross |
7.74M |
USD |
+5.27% |
Q1 2025 |
FY 2025 |
Deferred Income Tax Expense (Benefit) |
111K |
USD |
-81.9% |
Q2 2025 |
Q1 2026 |
Current Income Tax Expense (Benefit) |
1.86M |
USD |
-26.1% |
Q2 2025 |
Q1 2026 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2025 |
Q1 2026 |
Additional Paid in Capital |
1.93M |
USD |
-0.16% |
Q2 2025 |
Q1 2026 |
Depreciation, Depletion and Amortization |
486K |
USD |
+1.67% |
Q4 2024 |
Q3 2025 |